2BBBullish & Bearish
Health Care

Summit Therapeutics Inc. (SMMT) Stock Score & Signals

Summit Therapeutics Inc. (SMMT) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 55 out of 100.

2BB score and signals

Summit Therapeutics Inc.’s current 2BB score is 55 out of 100, built from the signal categories below.

SignalScoreReading
Activity74High
Momentum39Weakening
Financial strength41Normal
Risk22Low (provisional)

Company facts

FoundedAug 4, 2004
Employees61
52-week range$12.07 – $29.23

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-04-28—-0.3089—$9.39M
2027-02-22—-0.3933—$3.78M
2026-11-11—-0.2863—$68,003.00
2026-07-23—-0.2849—$0.00